Clinical Trials Logo

Breast Neoplasm clinical trials

View clinical trials related to Breast Neoplasm.

Filter by:

NCT ID: NCT05949983 Not yet recruiting - Breast Neoplasm Clinical Trials

Health Economic Evaluation of an Adapted Physical Activity Program for Women With Breast Cancer

EMEAPA
Start date: January 1, 2024
Phase: N/A
Study type: Interventional

Adapted physical activity (APA) was recognized as a non-drug therapy by the French Health Authority (HAS) in 2011. Very few studies have examined the efficiency of APA programs during the active phase of treatment in cancer patients. The investigators assumed that non-drug therapy such as APA could improve the quality of life and reduces health costs. The main objective of this study is to assess the efficiency of a standardized APA program, as compared to conventional management including simple recommendations for the practice of physical activity in women in phase active breast cancer treatment.

NCT ID: NCT05889988 Recruiting - Breast Neoplasm Clinical Trials

A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients

Start date: June 12, 2023
Phase:
Study type: Observational

Researchers plan to study the natural history of ado-trastuzumab emtansine (T-DM1)-induced neuropathy both in patients without any history of neuropathy or previous neurotoxic agent use and in patients who have such a history.

NCT ID: NCT05868187 Recruiting - Breast Neoplasm Clinical Trials

CanRestoreFunction Cancer-related Fatigue ( CRF )

CRF
Start date: March 1, 2023
Phase: N/A
Study type: Interventional

The goal of this randomized control trial is to determine if participating in an 8-week online cancer-related fatigue management intervention consisting of individualized exercise program, one-on-one goal setting and action plan development and interactive educational module will significantly reduce the perception of cancer-related fatigue, improve the quality of life, improve perceived cognition, and perceived function of breast cancer compared to a wait-list control group. The aim the project is to determine if an online cancerrelated fatigue management program is associated with 1. A decrease in cancer-related fatigue. 2. An improved perception of their ability and satisfaction in completing important activities 3. Greater quality of life. 4. Improved mobility 5. Improved perceived cognition

NCT ID: NCT05862610 Not yet recruiting - Breast Neoplasm Clinical Trials

The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC

Start date: July 30, 2023
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy and safety of trilaciclib combined with standard treatment project as a neoadjuvant treatment for triple negative breast cancer

NCT ID: NCT05633680 Active, not recruiting - Breast Neoplasm Clinical Trials

Circulating Tumor Cells Screen for Breast Cancer

CTCSFBC
Start date: February 20, 2020
Phase:
Study type: Observational [Patient Registry]

A prospective study was used to collect patients considering breast cancer admitted to our general surgery department from 2019-6 to 2023-8, to identify the case group (breast cancer) and the control group (non-breast cancer), to compare the differences in CTC in peripheral blood between the two groups, and to draw conclusions after statistical analysis.

NCT ID: NCT05604677 Completed - Breast Neoplasm Clinical Trials

Factor Influencing Breast Surgery Type Decision-Making

Start date: June 15, 2022
Phase:
Study type: Observational [Patient Registry]

The aim of this observational study is to determine the factors influencing the decision-making process for breast surgery type, in Lebanese women likely to face breast cancer. The main questions it aims to answer are the presence or not of a correlation between the type of choice and the following data: - Demographic - Health Status - Several factors that may influence the decision Participants will complete a well-structured and organized online survey

NCT ID: NCT05594095 Recruiting - Breast Cancer Clinical Trials

SNF Platform Study of HR+/ HER2-advanced Breast Cancer

Start date: December 30, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to establish a prospective, single-center platform research based on clinical subtypes to explore precision therapy in patients hormone-receptor-positive HER2-negative advanced breast cancer who had previously used CDK4/6 inhibitors.

NCT ID: NCT05582499 Recruiting - Breast Cancer Clinical Trials

Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy

FASCINATE-N
Start date: November 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to establish a prospective, single-center platform research based on clinical subtypes to explore precision neoadjuvant therapy in patients with operable breast cancer who met the indications for neoadjuvant chemotherapy and by the update of basic translational research in the center, especially the refinement of typing, the discovery of new targets and the development of novel targeted drugs, verified the effectiveness of new targeted drugs in neoadjuvant therapy.

NCT ID: NCT05576545 Completed - Breast Cancer Clinical Trials

Develop and Evaluate the Effectiveness of a Self-Care Smartphone Application on the Self-Efficacy, and Resilience Among Newly Diagnosed Breast Cancer Patients Undergoing Treatment

Start date: September 18, 2020
Phase: N/A
Study type: Interventional

This study was to develop and evaluate the self-efficacy and resilience of the Breast Cancer Self-Care App in newly diagnosed breast cancer patients undergoing chemotherapy.

NCT ID: NCT05505643 Recruiting - Breast Cancer Clinical Trials

Cryoablation vs Lumpectomy in T1 Breast Cancers

COOL-IT
Start date: April 3, 2024
Phase: N/A
Study type: Interventional

This trial studies the efficacy and safety of cryoablation in patients with low risk, early stage breast cancer. Cryoablation is a method of killing a tumor by freezing it. The standard approach for patients with this kind of cancer is a lumpectomy. This study will review the safety of the cryoablation procedure initially, followed by comparing cryoablation to lumpectomy in order to see if the cryoablation results in better disease control, complication rates, and quality of life.